Intelligent Bio Solutions Inc. financial data

Symbol
INBS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
135 W 41 St St,, Floor 5, New York, NY
State of incorporation
DE
Fiscal year end
June 30
Former names
GBS Inc. (to 10/18/2022), Glucose Biosensor Systems (Greater China) Holdings, Inc. (to 9/19/2019)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % +62.6%
Quick Ratio 15.2 % -4.72%
Debt-to-equity 80 % -35.4%
Return On Equity -147 % +34.4%
Return On Assets -81.1 % +18.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.25M shares -51.3%
Common Stock, Shares, Outstanding 4.38M shares +87.9%
Entity Public Float 5.99M USD +63.3%
Common Stock, Value, Issued 43.8K USD +87.8%
Weighted Average Number of Shares Outstanding, Basic 3.81M shares +1862%
Weighted Average Number of Shares Outstanding, Diluted 3.81M shares +1862%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 998K USD +10.2%
Revenue from Contract with Customer, Excluding Assessed Tax 3.19M USD +83%
Cost of Revenue 1.65M USD -6.79%
General and Administrative Expense 1.95M USD -20.7%
Operating Income (Loss) -10.5M USD +24.6%
Nonoperating Income (Expense) 28.8K USD -98.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.35M USD -373%
Net Income (Loss) Attributable to Parent -10.4M USD +12.1%
Earnings Per Share, Basic 5.4 USD/shares +94.4%
Earnings Per Share, Diluted 5.4 USD/shares +94.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.99M USD +2040%
Accounts Receivable, after Allowance for Credit Loss, Current 579K USD +1.95%
Inventory, Net 739K USD -23.4%
Other Assets, Current 396K USD -4.14%
Assets, Current 6.48M USD +141%
Property, Plant and Equipment, Net 586K USD -11.9%
Operating Lease, Right-of-Use Asset 261K USD -44.7%
Intangible Assets, Net (Excluding Goodwill) 4.4M USD -9.69%
Goodwill 3.8M USD
Other Assets, Noncurrent 505K USD +0.19%
Assets 11.7M USD +34.8%
Employee-related Liabilities, Current 478K USD +17.3%
Accrued Liabilities, Current 607K USD -21.9%
Liabilities, Current 5.68M USD -17%
Operating Lease, Liability, Noncurrent 28.1K USD -90.1%
Liabilities 5.78M USD -22.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -496K USD +16.4%
Retained Earnings (Accumulated Deficit) -54.6M USD -23.6%
Stockholders' Equity Attributable to Parent 6.1M USD +350%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.95M USD +381%
Liabilities and Equity 11.7M USD +34.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.39M USD -82%
Net Cash Provided by (Used in) Financing Activities 42.5K USD
Net Cash Provided by (Used in) Investing Activities -475K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.38M shares +87.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.31M USD -71.4%
Deferred Tax Assets, Valuation Allowance 10.4M USD +9.35%
Deferred Tax Assets, Gross 10.4M USD +9.35%
Operating Lease, Liability 310K USD -39.5%
Depreciation 6.41K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.3M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid 335K USD -43.8%
Property, Plant and Equipment, Gross 627K USD -13.4%
Operating Lease, Liability, Current 282K USD +23.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 83.5K USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year One 88K USD -59.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.1K USD -70.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 81.1K USD
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 61.2M USD +32.6%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets 940K USD -10.4%
Depreciation, Depletion and Amortization 242K USD -2.41%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%